Sort
130,381 grants matching “hiv”
Safety Evaluation of Anti-Infective Agents
$2,205,290Jon Carl Mirsalis · Sri International · N01 · FY2010 · AI
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,204,324Nanette Benbow · Chicago Department Of Public Health · U62 · FY2016 · PS
HIV Preventive Vaccine Studies
$2,204,214Barney Scott Graham · Niaid Extramural Activities · Z01 · FY2007 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,203,945University Of Kwazulu-Natal · U19 · FY2005 · AI
Brooklyn Women's Interagency HIV Study (WIHS) V
$2,203,744Howard Minkoff · Suny Downstate Medical Center · U01 · FY2016 · AI
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections- Small Clinical Trials Unit (SCTU)
$2,203,379Judith S. Currier · University Of California Los Angeles · UM1 · FY2025 · AI
Mechanisms Underlying Clearance of Persistent Infections and Tumors
$2,203,159Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$2,203,024Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Novel Adenovirus Vector-Based Vaccines for HIV-1
$2,202,559Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI
PERU Clinical Trial Unit
$2,202,177Jorge Luis Sanchez · Asociacion Civil Impacta Salud Y Educacn · UM1 · FY2024 · AI
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,201,109Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,200,921Myron E Essex · Harvard School Of Public Health · UM1 · FY2013 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$2,200,084James L. Sorensen · University Of California, San Francisco · UG1 · FY2019 · DA
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$2,200,000University Of Miami School Of Medicine · U10 · FY2000 · DA
CU PARTNERS: NY/LONG ISLAND REGIONAL NODE
$2,200,000New York State Psychiatric Institute · U10 · FY2001 · DA
The Infectious Diseases Clinical Research Program (IDCRP)
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
The Infectious Diseases Clinical Research Program
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE
$2,200,000Peter Savosnick · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2011 · PS
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE
$2,200,000Peter Savosnick · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2012 · PS
The Infectious Diseases Clinical Research Program (IDCRP)
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
Identification and validation of biomarkers of cervicovaginal mucosal alteration
$2,200,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2011 · AI
Vaccination against mucosal HIV clade C transmission
$2,199,333Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2010 · AI
Center for Translational Viral Oncology (CTVO)
$2,199,009John T. West · Lsu Health Sciences Center · P20 · FY2025 · GM
Center for Translational Viral Oncology (CTVO)
$2,199,009John T. West · Lsu Health Sciences Center · P20 · FY2024 · GM
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS
$2,198,847Therion Biologics Corporation · P01 · FY2002 · AI